31. MUCOSAL HEALING IN PATIENTS TREATED WITH INFLIXIMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS. (8th June 2013) Authors: Boyd, J; Lee, L; Lanzon-Miller, S Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. OC-059 Whole transcriptome analysis of colon cancer lymph node metastases reveals metastasis driver genes, signatures and effect of lymphoid ecological niche immune profile. (17th June 2017) Authors: Lee, L; Mills, LFreeman; Irshad, S; Wang, LM; Tomlinson, I Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. OC-062 A whole genome crispr knockout screen and murine endoscopy identifies foxf1 as a key suppressor of colorectal cancer metastasis that acts through mtorc signalling. (17th June 2017) Authors: Lee, L; Woolley, C; Lewis, A; Tomlinson, I Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. OC-087 Can faecal calprotectin reduce the demand for colonoscopy in patients with irritable bowel syndrome?. (23rd September 2015) Authors: Whitehead, S J; Lee, L; Fang, Z; Sisson, G; Hutton, J; Logan, R P H Journal: Gut Issue: Volume 59(2010)Supplement 1 Page Start: A36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. OC-094 TGF Beta1 Mediated EMT in CACO2BBE Gut Cells. (4th June 2013) Authors: Lee, L; Geevarghese, R; Heidtbreitch, F; Dockrell, M Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. P-039ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: results of a prospective single centre clinical utility study (PRECISE STUDY). (2nd July 2019) Authors: Lee, L; Starkey, T; Sivakumar, S; Fotheringham, S; Mozolowski, G; Shearwood, V; Palles, C; Camilleri, P; Kerr, R; Kerr, D Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. P.051 Patient-reported adverse events on Multiple Sclerosis disease-modifying therapies in an urban tertiary MS clinic. (17th June 2016) Authors: Liao, ZJ; Lee, L; Carr, K Journal: Canadian journal of neurological sciences Issue: Volume 43(2016)Supplement 2 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. P004 PN-943, an oral α4β7 integrin antagonist, inhibits MAdCAM1-mediated proliferation and cytokine release from CD4+ T cells independent of trafficking. (15th January 2020) Authors: CHENG, L; Venkataraman, S; Zhao, L; Lee, L; Tang, T; Liu, D; Mattheakis, L Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. P18 BPSU UK study of surgical closure of the patent ductus arteriosus – procedures and pathways. (2nd March 2016) Authors: Kelsall, W; Lakshmanan, A; Crosby, T; Lee, L Journal: Heart Issue: Volume 102(2016)Supplement 1 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. P625 Predictors of pancreatitis among patients with inflammatory bowel disease (IBD) treated with vedolizumab (VDZ): Observation from a large global safety database. (21st January 2022) Authors: Wernicke, J; Verstak, T; Zhang, T; Spalding, W; Lee, L; Cheng, Y; Ademi, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗